Cargando…

Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments

Immunotherapy that has proven efficacy in several solid cancers plays a partial role in improving clinical outcomes of advanced gastrointestinal (GI) cancers. There is an unmet need to find new immune-related therapeutic targets. Doublecortin-like kinase 1 (DCLK1) marks tuft cells which are recogniz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiangyan, Qu, Dongfeng, Weygant, Nathaniel, Peng, Jun, Houchen, Courtney W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073156/ https://www.ncbi.nlm.nih.gov/pubmed/31979136 http://dx.doi.org/10.3390/cancers12020274

Ejemplares similares

Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
por: Cao, Zhiyun, et al.
Publicado: (2020)

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
por: Sureban, Sripathi M., et al.
Publicado: (2015)

Dclk1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2014)

Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2017)

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
por: Sureban, Sripathi M., et al.
Publicado: (2013)

Dclk1(+) small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2015)

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases
por: Ali, Naushad, et al.
Publicado: (2015)

Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2016)

Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells
por: Chandrakesan, P, et al.
Publicado: (2016)

DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4
por: Panneerselvam, Janani, et al.
Publicado: (2020)

Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer
por: Qu, Dongfeng, et al.
Publicado: (2019)

DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
por: Weygant, Nathaniel, et al.
Publicado: (2014)

Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis
por: Qu, Dongfeng, et al.
Publicado: (2015)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)

DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers
por: Sureban, Sripathi M., et al.
Publicado: (2019)

Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression
por: Roy, Badal Chandra, et al.
Publicado: (2019)

Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma
por: Christman, Emily M., et al.
Publicado: (2019)

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
por: Weygant, Nathaniel, et al.
Publicado: (2014)

DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
por: Lorenzo, Nevi, et al.
Publicado: (2021)

Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation Injury
por: Sureban, Sripathi M., et al.
Publicado: (2015)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
por: Undi, Ram Babu, et al.
Publicado: (2022)

Role of platelet infiltration as independent prognostic marker for gastric adenocarcinomas
por: Wang, Jing, et al.
Publicado: (2020)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor Cells
por: Qu, Dongfeng, et al.
Publicado: (2015)

Activated K‐ras in Tumorigenic and Non‐tumorigenic Cell Variants from a Rat Colon Adenocarcinoma, Induced by Dimethylhydrazine
por: Caignard, Anne, et al.
Publicado: (1988)

High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors
por: IKEZONO, YU, et al.
Publicado: (2015)

IL7R Is Correlated With Immune Cell Infiltration in the Tumor Microenvironment of Lung Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment
por: Quan, Qiuying, et al.
Publicado: (2023)

DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma
por: Wang, Hui, et al.
Publicado: (2017)

ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19
por: Ahmadi, Mohsen, et al.
Publicado: (2021)

Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma
por: He, Aoxiao, et al.
Publicado: (2022)

Role of the Microenvironment in Gastrointestinal Tumors
por: Weygant, Nathaniel, et al.
Publicado: (2019)

Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
por: Ge, Yang, et al.
Publicado: (2022)

DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status
por: Yan, Rui, et al.
Publicado: (2023)

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014)

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications
por: O’Connell, Malaney R., et al.
Publicado: (2015)

Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
por: Ali, Naushad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lbsv5mj0em59hf582a7ach0oft